Pseudoerythromycin A enol ether

Pseudoerythromycin A enol ether (LY267108) is a degradation product of Erythromycin. Pseudoerythromycin A enol ether has no significant antimicrobial activity[1][2].

Product Specifications

CAS Number

[105882-69-7]

Product Name Alternative

LY267108

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Drug Metabolite

Type

Reference compound

Related Pathways

Metabolic Enzyme/Protease

Applications

Metabolism-protein/nucleotide metabolism

Field of Research

Others

Assay Protocol

https://www.medchemexpress.com/pseudoerythromycin-a-enol-ether.html

Purity

99.48

Solubility

10 mM in DMSO

Smiles

C[C@@](OC([C@@H]([C@]1([H])[C@](C)(O)[C@H](O)CC)C)=C2C)(C2)[C@@H]([C@H]([C@@H]([C@H](C(O1)=O)C)O[C@H](O[C@H]3C)C[C@](C)([C@H]3O)OC)C)O[C@H](O[C@@H]4C)[C@@H]([C@H](C4)N(C)C)O

Molecular Formula

C37H65NO12

Molecular Weight

715.91

Precautions

H302, H315, H319, H335

References & Citations

[1]Pendela M, et al. Combined use of liquid chromatography with mass spectrometry and nuclear magnetic resonance for the identification of degradation compounds in an erythromycin formulation. Anal Bioanal Chem. 2012;402 (2) :781-790.|[2]Greenwood B, et al. Effects of LY267108, an erythromycin analogue derivative, on lower esophageal sphincter function in the cat. Gastroenterology. 1994;106 (3) :624-628.